The (now former) CEO of Masimo was apparently anti-Apple and had no interest in striking a licensing deal. Now that there's new leadership things might be different. We shall see.I think Apple will pay the money to buy Masimo or there patents as they paid Intel $1 Billion for there portfolio of modem patents. [...] I think Tim Cook gets this settled in the next year or so and the blood oxygen will be back.
I have never upgraded my watch yearly (S3 -> S6 -> S9) but the S10 really tempted me– namely, the titanium version which is only a couple of grams heavier than my current aluminum S9 but has the sapphire screen. However, the lack of blood oxygen sensor ultimately kept me from upgrading, as I want to use the sleep tracking and vitals stuff from WatchOS 11.
I recently read that Masimo's CEO was recently ousted, so I'm wondering if the new leadership will be willing to play ball with Apple.
Yes, it is possible the new CEO & board may be interested in licensing while reported the former were not. Question is then whether they're willing to do so at a price that Apple would be willing to pay -- and that will depend on what Apple thinks the impact on sales might be due to disabled sensor.
As for sleep tracking - you should be able to sleep track and use the Vitals app with the S10, you just wouldn't get the blood oxygen data. You also could consider buying the S10 and retaining the S9 to use while sleeping, thus avoiding any concerns about charging. Thirdly you could just do sleep tracking with the S9 and not buy a S10.